Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - midazolam -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - ketorolac trometamol -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - ketorolac trometamol -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - capecitabine -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - metformin hydrochloride -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - gabapentin, quantity: 300 mg - capsule - excipient ingredients: lactose monohydrate; maize starch; purified talc; gelatin; purified water; sodium lauryl sulfate; titanium dioxide; iron oxide yellow - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. gabapentin is indicated for the treatment of neuropathic pain.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - gabapentin, quantity: 100 mg - capsule - excipient ingredients: lactose monohydrate; maize starch; purified talc; gelatin; purified water; sodium lauryl sulfate; titanium dioxide - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. gabapentin is indicated for the treatment of neuropathic pain.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

apotex nz ltd - linezolid 600mg - film coated tablet - 600 mg - active: linezolid 600mg excipient: colloidal silicon dioxide crospovidone hyprolose hypromellose macrogol 8000 magnesium stearate methylcellulose titanium dioxide - linezolid apotex is indicated for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: · pneumonia - community acquired and nosocomial pneumonia · skin and soft tissue infections · enterococcal infections. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected. consideration should be given to official guidance on the appropriate use of antibacterial agents.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - pioglitazone hydrochloride -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - fluconazole, quantity: 200 mg - capsule, hard - excipient ingredients: purified water; lactose monohydrate; maize starch; patent blue v; magnesium stearate; titanium dioxide; erythrosine; gelatin; colloidal anhydrous silica; sodium lauryl sulfate - fluconazole apotex (fluconazole) capsules, given orally, are indicated for the following conditions: - treatment of cryptococcal meningitis in patients who are unable to tolerate amphotericin b. note: data suggest that the clinical efficacy of fluconazole is lower than that of amphotericin b in the acute phase of cryptococcal meningitis. - maintenance therapy to prevent relapse of cryptococcal meningitis in patients with aids. - treatment of oropharyngeal and oesophageal candidiasis in aids and other immunosuppressed patients. - secondary prophylaxis of oropharyngeal candidiasis in patients with hiv infection. - serious and life-threatening candida infections in patients who are unable to tolerate amphotericin b. note: it remains to be shown that fluconazole is as effective as amphotericin b in the treatment of serious and life-threatening candida infecctions. until such data are available, amphotericin b remains the drug of choice. - vaginal candidiasis, when topical therapy has failed. - treatment of extensive tinea corporis, extensive tinea cruris and extensive tinea pedis infections in immunocompetent patients in whom topical therpy is not a practical treatment option. usually, topical therapy should be attempted first because oral therapy has a less favourable ratio of benefits to risks.